Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?

被引：0
|
作者：
Teo, Koon K. [1 ]
机构：
[1] McMaster Univ, Med Ctr, Div Cardiol, Dept Med, Hamilton, ON L8N 3Z5, Canada
来源：
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2009年 / 119卷 / 1-2期
关键词：
VENTRICULAR SYSTOLIC FUNCTION; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; RANDOMIZED TRIAL; DYSFUNCTION; TELMISARTAN; CANDESARTAN; INTOLERANT; MORBIDITY; CAPTOPRIL;
D O I：
10.20452/pamw.590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 10
页数：3
相关论文
共 50 条
  • [41] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?
    Xiao, Lin
    Ouyang, Haichun
    Su, Qiwen
    Huang, Yuli
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 56 - 57
  • [42] Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis
    Baranchuk, AM
    Healey, J
    Crystal, E
    Yusuf, S
    Connolly, SJ
    [J]. CIRCULATION, 2004, 110 (17) : 461 - 461
  • [43] A comparative study assessing the incidence and degree of hyperkalemia in patients on angiotensin-converting enzyme inhibitors versus angiotensin-receptor blockers
    Jonathan R. Salik
    Sara B. Golas
    Thomas H. McCoy
    [J]. Journal of Human Hypertension, 2022, 36 : 485 - 487
  • [44] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Shrimpton, A. J.
    Walker, S. L. M.
    Ackland, G. L.
    [J]. BJA EDUCATION, 2020, 20 (11) : 362 - 367
  • [45] CARDIAC EVENTS OCCURRING DURING THE COURSE OF THE USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS/ANGIOTENSIN-RECEPTOR BLOCKERS IN FABRY DISEASE PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY
    Warnock, D. C.
    [J]. CLINICAL THERAPEUTICS, 2008, 30 : S110 - S111
  • [46] Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1222 - 1230
  • [47] In reply - Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (07) : 1553 - 1556
  • [48] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Liu, Chia-Lin
    Shau, Wen-Yi
    Chang, Chia-Hsuin
    Wu, Chi-Shin
    Lai, Mei-Shu
    [J]. JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
  • [49] Anti-inflammatory action of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Mascitelli, L
    Pezzetta, F
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 889 - 889
  • [50] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Xiao-Long Li
    Tao Li
    Qi-Cong Du
    Li Yang
    Kun-Lun He
    [J]. World Journal of Clinical Cases, 2021, 9 (20) : 5462 - 5469
12345